A recent study found that pentanoate induced epigenetic reprogramming of T cells by inhibiting class 1 histone deacetylases, increasing mTOR activity in CD8+ T cells, and enhancing expression of CD25 and IL-2, which empirically increased anti-tumor activity of CD8+ T cells treated with these short-chain fatty acids (96). Here, CD8A is linked to neoplasm.